When was Deciphex founded?

Deciphex was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Deciphex located?

Deciphex is headquartered in Dublin, Ireland.

Who is the current CEO of Deciphex?

Donal O’Shea of Deciphex. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Deciphex have?

As of Sep 30, 2026, the latest employee count at Deciphex is 177.

Is Deciphex a funded company?

Deciphex is a funded company, having raised a total of $56.6M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 12, 2017.

When was the latest funding round of Deciphex?

Deciphex's latest funding was a $***** Venture Debt round on Oct 02, 2025, with participation from 1 investor.

Where does Deciphex rank among its competitors?

Deciphex ranks 20th amongst 448 active competitors, of which 66 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Deciphex?

Deciphex's top competitors include PathAI, Ovation and Cirdan Imaging. Among them, Techcyte secured the most recent funding round in April, 2026.

Deciphex - 2026 Company Profile, Team, Funding & Competitors

Deciphex is a series C company based in Dublin (Ireland), founded in 2017 by Donal O’Shea and Mark Gregson. It operates as a Network of pathologists providing digital diagnostic services for medical testing. Deciphex has raised $56.6M in funding from investors like Halo Business Angel Network, Seroba Life Sciences and Molten Ventures. The company has 448 active competitors, including 66 funded and 57 that have exited. Its top competitors include companies like PathAI, Ovation and Cirdan Imaging.

Company Details

Network of pathologists providing digital diagnostic services for medical testing. These services utilize artificial intelligence to assist in the analysis of tissue samples and clinical slides. The platform integrates with existing healthcare systems to facilitate remote review of diagnostic data. By digitizing workflows, the system supports the assessment of biological samples for clinical and research purposes. The technology assists in identifying lesions and evaluating diagnostic findings to support medical decision making.

Website: www.deciphex.com/
Social
Email ID: *****@deciphex.com
Phone Number: +353 **********

Key Metrics

Founded Year

2017

Location

Dublin, Ireland

Stage

Series C

Total Funding

$56.6M in 13 rounds

Latest Funding Round

Venture Debt, Oct 02, 2025, $*****

Investors

Halo Business Angel Network & 14 more

Ranked

20^th among 448 active competitors

Employee Count

177 as on Sep 30, 2026

Investment & Acquisitions

Id-Pal

Similar Companies

OpenEvidence & 3384 more

View Deciphex's full profile

Deciphex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Deciphex Inc. CIN: 20241361756 , United States, Deadpooled	Mar 27, 2024	-	-	-

Deciphex has raised a total funding of $56.6M over 13 rounds. Its first funding round was on Jan 12, 2017. Its latest funding round was a Venture Debt round on Oct 02, 2025 for $*****. 1 investor participated in its latest round. Deciphex has 15 institutional investors.

Here is the list of recent funding rounds of Deciphex:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 02, 2025	1502543	Venture Debt	9135131	1120058	4887280	4349271
Jan 07, 2025	9445603	Series C	2456732	2898717	3320871	Act Venture Capital & 5 more
Oct 16, 2023	1299418	Venture Debt	1646348	5191049	2966092	Claret Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of Deciphex's funding rounds and investors

The founders of Deciphex are Donal O’Shea and Mark Gregson. Donal O’Shea is the CEO of Deciphex.

Here are the details of Deciphex's key team members:

Donal O’Shea: Co-Founder & CEO of Deciphex and founder of 1 other company. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Mark Gregson: Co-Founder of Deciphex and founder of 1 other company.
Contact Info: 1 email address

View details of Deciphex's Founder profiles and Board Members

Deciphex's employee count trend

Deciphex has 177 employees as of Sep 26. Here is Deciphex's employee count trend over the years:

Uncover Deciphex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Deciphex include PathAI, Ovation and Cirdan Imaging. Here is the list of Top 10 competitors of Deciphex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	72/100
2nd	Ovation 2009, Cambridge (United States), Series B	Provider of a cloud-based laboratory information and data management platform for researchers and clinicians	$33.3M	SignalFire, Madrona & 8 others	69/100
3rd	Cirdan Imaging 2010, Lisburn (United Kingdom), Series B	Laboratory Information System for clinical laboratories	$27.6M	Invest Northern Ireland, Kernel Capital & 41 others	65/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
6th	Quartzy 2009, Hayward (United States), Series C	Provider of web-based platform for labs management	$56.9M	Eminence Capital, Orthogonal Thinker & 20 others	64/100
7th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
8th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
9th	Uncountable Data 2016, San Francisco (United States), Series A	Developer of a unified platform for research and development data management	$27M	Sageview Capital, MK Capital & 4 others	61/100
10th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
20th	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Irrus Investments, Molten Ventures & 13 others	54/100